Update

Medical Receivables Yield Fund returned 12.2% in 2025

Proof Capital logo

Proof Capital's Medical Receivables Yield Fund returned 12.2% in 2025 on its Class F (USD) units, net of fund expenses, according to its overview as of December 31, 2025.

  • 2025 return: 12.2%
  • 2024 return: 15.6%
  • 2023 return: 12.0%
  • Net annualized since inception: 13.9%

The fund holds secured high yield loans and profit sharing agreements backed by insured North American medical receivables. It is open-ended, investors can redeem at the end of any month, and returns are either paid in cash monthly or reinvested.

The fund facts list a 6% hurdle rate with a high water mark. Proof says the fund has had less than a 0.1 correlation to the S&P TSX since inception.

Equity Market exists to make private-market investing as transparent as public markets. It is an online portal for researching and comparing private-market real estate and alternative investments: figures carrying their source, manager updates and planning tools.

Equity Market
© 2026 Equity MarketTerms of servicePrivacy policy